Brian Albarran, Ph.D. - Publications

Affiliations: 
2005 University of Washington, Seattle, Seattle, WA 
Area:
Biomedical Engineering, Cell Biology, Pharmacy

5 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2011 Albarran B, Hoffman AS, Stayton PS. Efficient Intracellular Delivery of a Pro-Apoptotic Peptide With A pH-Responsive Carrier. Reactive & Functional Polymers. 71: 261-265. PMID 21499545 DOI: 10.1016/J.Reactfunctpolym.2010.09.008  0.553
2007 Rinne J, Albarran B, Jylhävä J, Ihalainen TO, Kankaanpää P, Hytönen VP, Stayton PS, Kulomaa MS, Vihinen-Ranta M. Internalization of novel non-viral vector TAT-streptavidin into human cells. Bmc Biotechnology. 7: 1. PMID 17199888 DOI: 10.1186/1472-6750-7-1  0.639
2006 Rinne J, Albarran B, Jylhävä J, Ihalainen TO, Kankaanpää P, Hytönen VP, Stayton PS, Kulomaa MS, Vihinen-Ranta M. 188. Internalization of Novel Delivery Vector TAT-Streptavidin into Human Cells Molecular Therapy. 13: S73. DOI: 10.1016/J.Ymthe.2006.08.212  0.649
2005 Albarran B, To R, Stayton PS. A TAT-streptavidin fusion protein directs uptake of biotinylated cargo into mammalian cells. Protein Engineering, Design & Selection : Peds. 18: 147-52. PMID 15820981 DOI: 10.1093/Protein/Gzi014  0.613
2005 Albarran B, To R, Stayton P. 1111. TAT-Streptavidin: A Novel Drug Delivery Vector for the Intracellular Uptake of Macromolecular Cargo Molecular Therapy. 11. DOI: 10.1016/J.Ymthe.2005.07.659  0.602
Show low-probability matches.